RecruitingNot Applicable

Playing Game to Learn About Children's Vaccine Project

United States180 participantsStarted 2025-10-27

Plain-language summary

This proposed study aims to conduct timely research that promotes vaccine confidence and vaccination of one strongly recommended vaccine with suboptimal uptake rates: Human papillomavirus (HPV) in vulnerable and underserved youth aged 11-14.

Who can participate

Age range

11 Years – 14 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Child sample: (1) 11-14 years old, (2) speaks and reads English, (3) has never received any doses of the HPV vaccine, (4) is not currently enrolled in another project that involves HPV-related education, and (5) agrees and provides assent to participate in research activities. * Parent sample: (1) parent or legal guardian of the participating child, (2) speak and read English, (3) own a smartphone, (4) agree to receive email and text messages, (5) is not currently enrolled in another project that involves HPV-related education, and (6) agree and provide consent to participate in research activities. Exclusion Criteria: Individuals who do not meet inclusion criteria or refuse to provide consent/assent.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Percentage of eligible individuals agreeing to participate

Timeframe: T0 (occurs after consenting and before assigning to different study conditions)

Proportion of participants who are retained through follow-up

Timeframe: T2 (occurs two months after completion of the intervention)

Percentage of participants who complete the intervention and assessments

Timeframe: T2 (occurs two months after completion of the intervention)

Participant satisfaction with the project

Timeframe: T2 (occurs two months after completion of the intervention)

Intention to vaccinate the children against HPV

Timeframe: T0 (occurs after consenting and before assigning to different study conditions); T1 (occurs immediately post intervention);T2 (occurs two months after completion of the intervention)

Trial details

NCT IDNCT05984849

SponsorMichigan State University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-06-30

Contact for this trial

ANGELA CHEN, PhD

(517) 884-4645 VaccineHealthGame@msu.edu

View on ClinicalTrials.gov More HPV trials

Who can participate

Age range

11 Years – 14 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Percentage of eligible individuals agreeing to participate

Timeframe: T0 (occurs after consenting and before assigning to different study conditions)

Proportion of participants who are retained through follow-up

Timeframe: T2 (occurs two months after completion of the intervention)

Percentage of participants who complete the intervention and assessments

Timeframe: T2 (occurs two months after completion of the intervention)

Participant satisfaction with the project

Timeframe: T2 (occurs two months after completion of the intervention)

Intention to vaccinate the children against HPV

Timeframe: T0 (occurs after consenting and before assigning to different study conditions); T1 (occurs immediately post intervention);T2 (occurs two months after completion of the intervention)